Journal
ACS CHEMICAL BIOLOGY
Volume 8, Issue 3, Pages 519-523Publisher
AMER CHEMICAL SOC
DOI: 10.1021/cb300510w
Keywords
-
Categories
Funding
- Global Alliance for Tuberculosis (GATB)
Ask authors/readers for more resources
Aminopyrazinamides originated from a high throughput screen targeting the Mycobacterium smegmatis (Msm) GyrB ATPase. This series,displays chemical tractability, robust structure-activity relationship, and potent antitubercular activity. The crystal structure of Msm GyrB in complex with one of the aminopyrazinamides revealed promising attributes of specificity against other broad spectrum pathogens and selectivity against eukaryotic kinases due to novel interactions at hydrophobic pocket, unlike other known GyrB inhibitors. The aminopyrazinamides display excellent mycobacterial kill under in vitro, intracellular, and hypoxic conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available